首页> 外文期刊>Analytical and bioanalytical chemistry >Excretion kinetics of ~(13)C-urea breath test: influences of endogenous CO_2 production and dose recovery on the diagnostic accuracy of Helicobacter pylori infection
【24h】

Excretion kinetics of ~(13)C-urea breath test: influences of endogenous CO_2 production and dose recovery on the diagnostic accuracy of Helicobacter pylori infection

机译:〜(13)C-尿呼气试验的排泄动力学:内源性CO_2产生和剂量恢复对幽门螺杆菌感染诊断准确性的影响

获取原文
获取原文并翻译 | 示例
           

摘要

We report for the first time the excretion kinetics of the percentage dose of ~(13)C recovered/h (~(13)C-PDR %/h) and cumulative PDR, i.e. c-PDR (%) to accomplish the highest diagnostic accuracy of the ~(13)C-urea breath test (~(13)C-UBT) for the detection of Helicobacter pylori infection without any risk of diagnostic errors using an optical cavity-enhanced integrated cavity output spectroscopy (ICOS) method. An optimal diagnostic cut-off point for the presence of H. pylori infection was determined to be c-PDR (%)=1.47%at 60min, using the receiver operating characteristic curve (ROC) analysis to overcome the “grey zone” containing false-positive and falsenegative results of the ~(13)C-UBT. The present ~(13)C-UBT exhibited 100 % diagnostic sensitivity (true-positive rate) and 100 % specificity (true-negative rate) with an accuracy of 100 % compared with invasive endoscopy and biopsy tests. Our c-PDR (%) methodology also manifested both diagnostic positive and negative predictive values of 100 %, demonstrating excellent diagnostic accuracy. We also observed that the effect of endogenous CO_2 production related to basal metabolic rates in individuals was statistically insignificant (p= 0.78) on the diagnostic accuracy. However, the presence of H. pylori infection was indicated by the profound effect of urea hydrolysis rate (UHR). Our findings suggest that the current c-PDR (%) is a valid and sufficiently robust novel approach for an accurate, specific, fast and noninvasive diagnosis of H. pylori infection, which could routinely be used for large-scale screening purposes and diagnostic assessment, i.e. for early detection and follow-up of patients.
机译:我们首次报告了〜(13)C回收的百分比剂量/ h(〜(13)C-PDR%/ h)和累积PDR的排泄动力学,即c-PDR(%)完成了最高的诊断〜(13)C-尿素呼气试验(〜(13)C-UBT)使用光学腔增强型集成腔输出光谱(ICOS)方法检测幽门螺杆菌感染而没有任何诊断错误风险的准确性。使用接收器工作特征曲线(ROC)分析来克服包含假阳性的“灰色区域”,确定幽门螺杆菌感染的最佳诊断临界点是60分钟时c-PDR(%)= 1.47% (13)C-UBT的阳性和假阴性结果。与有创内窥镜检查和活检相比,本发明的〜(13)C-UBT表现出100%的诊断敏感性(真阳性率)和100%的特异性(真阴性率),准确度为100%。我们的c-PDR(%)方法还显示出100%的诊断阳性和阴性预测值,证明了极好的诊断准确性。我们还观察到,与个体基础代谢率相关的内源性CO_2产生对诊断准确性的影响在统计学上不显着(p = 0.78)。但是,尿素水解率(UHR)的深远影响表明了幽门螺杆菌感染的存在。我们的发现表明,当前的c-PDR(%)是一种有效,足够强大的新颖方法,可准确,特异性,快速且无创地诊断幽门螺杆菌感染,可常规用于大规模筛查和诊断评估,即用于患者的早期发现和随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号